Proper anonymization of that kind of detailed data is a hard problem. There are PhDs and Post-docs and Professors working in that field, and it's non-trivial. Just removing PII won't get you very far, as is obvious by the contents of the reviews.
I don't know how concerned PF really is by all of this, but if they did care about patient privacy, then one would think that they should've done this all from the start with privacy in mind -- or, now, that they would start hiring a privacy red team to shake things up.
Unfortunately, given how non-existent privacy laws and norms are here in the states, I would be surprised if much changed.
HIPAA exists in the States.
http://www.nytimes.com/2009/08/09/business/09privacy.html?pa...
Most big pharmacy chains have, at one point or another, been accused of selling actual prescription data to drug company marketers.
While not well-known, this is quite common and legal practice. Insurance and pharma companies have been buying deidentified data for years now. It is usually only for the purposes of research. HIPAA itself has deidentification guidelines which must be followed. They aren't fool-proof though, there have been some successful attempts at reidentification. Ironically many of the contracts specify that you cannot try to reidentify the data you buy.
How the hell is this allowed?
Has anyone tried to de-de-identify the data?